{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:29:17Z","timestamp":1792787357172,"version":"4.5.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.yexmp.2018.11.008","type":"journal-article","created":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T12:19:18Z","timestamp":1542629958000},"page":"44-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Molecular and cellular genetics of non-Hodgkin lymphoma: Diagnostic and prognostic implications"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7457-737X","authenticated-orcid":false,"given":"Suraj","family":"Pratap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa S.","family":"Scordino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6769","key":"10.1016\/j.yexmp.2018.11.008_bb0005","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.yexmp.2018.11.008_bb0010","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1097\/PAS.0b013e3182549b50","article-title":"Application of a BRAF V600E mutation-specific antibody for the diagnosis of hairy cell leukemia","volume":"36","author":"Andrulis","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"issue":"20","key":"10.1016\/j.yexmp.2018.11.008_bb0015","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1200\/JCO.2009.26.3947","article-title":"Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab","volume":"28","author":"Barrans","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.yexmp.2018.11.008_bb0020","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.20031175","article-title":"Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptors","volume":"199","author":"Basso","year":"2004","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.yexmp.2018.11.008_bb0025","first-page":"2975","article-title":"Nonrandom chromosome abnormalities in lymphoma","volume":"43","author":"Bloomfield","year":"1983","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.yexmp.2018.11.008_bb0030","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1182\/blood-2016-03-707141","article-title":"Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma","volume":"128","author":"Boddicker","year":"2016","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.yexmp.2018.11.008_bb0035","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1365-2141.1995.tb05429.x","article-title":"Increased expression of the PRAD-1\/CCND1 gene in hairy cell leukaemia","volume":"91","author":"Bosch","year":"1995","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.yexmp.2018.11.008_bb0040","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1182\/blood.V101.3.1149","article-title":"Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t (14; 18), 3q27, or other translocations: t (14; 18) and 3q27 are mutually exclusive","volume":"101","author":"Bosga-Bouwer","year":"2003","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.yexmp.2018.11.008_bb0045","first-page":"935","article-title":"Rappaport classification of non-Hodgkin's lymphoma: histologic features and clinical significance","volume":"61","author":"Byrne","year":"1977","journal-title":"Cancer Treatment Reports"},{"key":"10.1016\/j.yexmp.2018.11.008_bb0050","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, revised 4th edn","first-page":"216","article-title":"Chronic lymphocytic leukaemia\/Small lymphocytic lymphoma","author":"Campo","year":"2017"},{"issue":"5","key":"10.1016\/j.yexmp.2018.11.008_bb0055","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/bjh.13200","article-title":"CXCR4 WHIM-like frameshift and nonsense mutations promote ibrutinib resistance but do not supplant MYD88L265P-directed survival signalling in Waldenstr\u00f6m macroglobulinaemia cells","volume":"168","author":"Cao","year":"2015","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.yexmp.2018.11.008_bb0060","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1046\/j.1365-2141.1997.3573171.x","article-title":"Point mutations of the BCL-6 gene in Burkitt's lymphoma","volume":"99","author":"Capello","year":"1997","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.yexmp.2018.11.008_bb0065","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","article-title":"ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes","volume":"124","author":"Castellar","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.yexmp.2018.11.008_bb0070","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.yexmp.2018.11.008_bb0075","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/(SICI)1098-2264(199906)25:2<123::AID-GCC8>3.0.CO;2-4","article-title":"Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas","volume":"25","author":"Cigudosa","year":"1999","journal-title":"Genes Chromosom. Cancer"},{"issue":"7247","key":"10.1016\/j.yexmp.2018.11.008_bb0080","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nature07968","article-title":"Mutations of multiple genes cause deregulation of NF-\u03baB in diffuse large B-cell lymphoma","volume":"459","author":"Compagno","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.yexmp.2018.11.008_bb7755","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"259","article-title":"Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue","author":"Cook","year":"2017"},{"key":"10.1016\/j.yexmp.2018.11.008_bb0085","series-title":"Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma [Published Correction Appears in Cancer Cell]","first-page":"744","article-title":"T-cell project: Prospective collection of data in patients with peripheral T-cell lymphoma and the AIRC 5xMille consortium \u201cGenetics-driven targeted management of lymphoid malignancies\u201d","volume":"27(5)","author":"Crescenzo","year":"2015"},{"issue":"24","key":"10.1016\/j.yexmp.2018.11.008_bb0090","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.1073\/pnas.79.24.7824","article-title":"Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells","volume":"79","author":"Dalla-Favera","year":"1982","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.yexmp.2018.11.008_bb0095","series-title":"Paper Presented at: Seminars in Cancer Biology","article-title":"MALT lymphoma: A paradigm of NF-\u03baB dysregulation","author":"Du","year":"2016"},{"issue":"7","key":"10.1016\/j.yexmp.2018.11.008_bb0100","first-page":"1190","article-title":"Ongoing mutation in MALT lymphoma immunoglobulin gene suggests that antigen stimulation plays a role in the clonal expansion","volume":"10","author":"Du","year":"1996","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.yexmp.2018.11.008_bb0105","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1182\/blood.V91.12.4677","article-title":"Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma","volume":"91","author":"Elenitoba-Johnson","year":"1998","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.yexmp.2018.11.008_bb0110","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood-2017-04-779736","article-title":"TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy","volume":"130","author":"Eskelund","year":"2017","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.yexmp.2018.11.008_bb0115","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/gcc.20754","article-title":"Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma","volume":"49","author":"Espinet","year":"2010","journal-title":"Genes Chromosom. Cancer"},{"issue":"25","key":"10.1016\/j.yexmp.2018.11.008_bb0120","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.1182\/blood-2011-05-357251","article-title":"General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL","volume":"118","author":"Fazi","year":"2011","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.yexmp.2018.11.008_bb0125","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1182\/blood.V88.10.4005.bloodjournal88104005","article-title":"Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules","volume":"88","author":"Foss","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.yexmp.2018.11.008_bb0130","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, revised 4th edn","first-page":"226","article-title":"Hairy cell leukaemia","author":"Foucar","year":"2017"},{"issue":"10","key":"10.1016\/j.yexmp.2018.11.008_bb0135","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrc3580","article-title":"Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology","volume":"13","author":"Hallberg","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.yexmp.2018.11.008_bb0140","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","article-title":"Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute\u2013Working Group 1996 guidelines","volume":"111","author":"Hallek","year":"2008","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.yexmp.2018.11.008_bb0145","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig V H genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.yexmp.2018.11.008_bb0150","first-page":"149","article-title":"AIDS-related lymphoma. Histopathology, immunophenotype, and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization","volume":"138","author":"Hamilton-Dutoit","year":"1991","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.yexmp.2018.11.008_bb0155","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.yexmp.2018.11.008_bb0160","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1023\/A:1008375931236","article-title":"The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997","volume":"10","author":"Harris","year":"1999","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.yexmp.2018.11.008_bb0165","first-page":"169","article-title":"A variant translocation t (2; 18) in follicular lymphoma involves the 5'end of bcl-2 and Ig kappa light chain gene","volume":"6","author":"Hillion","year":"1991","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.yexmp.2018.11.008_bb0170","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1182\/blood-2003-04-1359","article-title":"Relationship between REL amplification, REL function, and clinical and biologic features in diffuse large B-cell lymphomas","volume":"103","author":"Houldsworth","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.yexmp.2018.11.008_bb0175","series-title":"SEER Cancer Statistics Review, 1975\u20132015","author":"Howlader","year":"2015"},{"issue":"1","key":"10.1016\/j.yexmp.2018.11.008_bb0180","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1053\/j.seminoncol.2011.11.007","article-title":"Pathologic and molecular genetic features of chronic lymphocytic leukemia","volume":"39","author":"Hsi","year":"2012","journal-title":"Semin. Oncol."},{"issue":"7","key":"10.1016\/j.yexmp.2018.11.008_bb0185","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1182\/blood.V99.7.2285","article-title":"The t (14; 18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile","volume":"99","author":"Huang","year":"2002","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.yexmp.2018.11.008_bb0190","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","article-title":"Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma","volume":"123","author":"Iqbal","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.yexmp.2018.11.008_bb0195","series-title":"Classification of Natural Killer (NK) Cell and NK-Like T-Cell Malignancies [Editorial; Comment]","author":"Jaffe","year":"1996"},{"key":"10.1016\/j.yexmp.2018.11.008_bb0200","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, revised 4th edn","first-page":"285","article-title":"Follicular lymphoma","author":"Jaffe","year":"2017"},{"key":"10.1016\/j.yexmp.2018.11.008_bb9555","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"190","article-title":"Introduction and overview of the classification of lymphoid neoplasms","author":"Jaffe","year":"2017"},{"issue":"38","key":"10.1016\/j.yexmp.2018.11.008_bb0205","doi-asserted-by":"crossref","first-page":"62627","DOI":"10.18632\/oncotarget.11548","article-title":"Recurrent mutations in NF-\u03baB pathway components, KMT2D, and NOTCH1\/2 in ocular adnexal MALT-type marginal zone lymphomas","volume":"7","author":"Johansson","year":"2016","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.yexmp.2018.11.008_bb5555","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1182\/blood-2007-12-130229","article-title":"Use of IGHV3\u201321 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post\u2013germinal center leukemogenic selection","volume":"111","author":"Ghia","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.yexmp.2018.11.008_bb0210","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/leu.2017.251","article-title":"Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets","volume":"32","author":"Karube","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.yexmp.2018.11.008_bb0215","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1600-065X.1998.tb01447.x","article-title":"Somatic hypermutation in normal and transformed human B cells","volume":"162","author":"Klein","year":"1998","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.yexmp.2018.11.008_bb0220","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, revised 4th edn","first-page":"335","article-title":"High-grade B cell lymphoma","author":"Kluin","year":"2017"},{"issue":"5","key":"10.1016\/j.yexmp.2018.11.008_bb0225","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1182\/blood-2006-06-028969","article-title":"Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes","volume":"109","author":"Lamant","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.yexmp.2018.11.008_bb0230","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, revised 4th edn","first-page":"330","article-title":"Burkitt lymphoma","author":"Leoncini","year":"2017"},{"issue":"11","key":"10.1016\/j.yexmp.2018.11.008_bb0235","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.humpath.2008.04.007","article-title":"Translocation (18; 22)(q21; q11) in B-cell lymphomas: a report of 4 cases and review of the literature","volume":"39","author":"Lin","year":"2008","journal-title":"Hum. Pathol."},{"issue":"8","key":"10.1016\/j.yexmp.2018.11.008_bb0240","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1182\/blood.V82.8.2289.2289","article-title":"p53 mutations are associated with histologic transformation of follicular lymphoma","volume":"82","author":"Lo Coco","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.yexmp.2018.11.008_bb0245","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/ijlh.12817","article-title":"The 2017 WHO update on mature T-and natural killer (NK) cell neoplasms","volume":"40","author":"Matutes","year":"2018","journal-title":"Int. J. Lab. Hematol."},{"issue":"6","key":"10.1016\/j.yexmp.2018.11.008_bb0250","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/modpathol.2009.34","article-title":"Novel immunophenotypic features of marrow lymphoplasmacytic lymphoma and correlation with Waldenstr\u00f6m's macroglobulinemia","volume":"22","author":"Morice","year":"2009","journal-title":"Mod. Pathol."},{"issue":"7360","key":"10.1016\/j.yexmp.2018.11.008_bb0255","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.yexmp.2018.11.008_bb9955","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States","volume":"107","author":"Morton","year":"2006","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.yexmp.2018.11.008_bb0260","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nrc3090","article-title":"Cyclin D as a therapeutic target in cancer","volume":"11","author":"Musgrove","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.yexmp.2018.11.008_bb0265","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2141.2008.07042.x","article-title":"Cytogenetic abnormalities and clinical correlations in peripheral T-cell lymphoma","volume":"141","author":"Nelson","year":"2008","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.yexmp.2018.11.008_bb0270","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1309\/4LCN-JMPG-5U71-UWQB","article-title":"Waldenstr\u00f6m macroglobulinemia: development of diagnostic criteria and identification of prognostic factors","volume":"116","author":"Owen","year":"2001","journal-title":"Am. J. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.yexmp.2018.11.008_bb0275","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.seminhematol.2015.01.005","article-title":"The genetic landscape of diffuse large B-cell lymphoma","volume":"52","author":"Pasqualucci","year":"2015","journal-title":"Semin. Hematol."},{"issue":"8","key":"10.1016\/j.yexmp.2018.11.008_bb0280","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1182\/blood-2002-11-3387","article-title":"Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma","volume":"101","author":"Pasqualucci","year":"2003","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.yexmp.2018.11.008_bb0285","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S1470-2045(15)00169-2","article-title":"Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry","volume":"16","author":"Pastore","year":"2015","journal-title":"Lancet Oncol."},{"issue":"9","key":"10.1016\/j.yexmp.2018.11.008_bb0290","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1073\/pnas.83.9.2984","article-title":"Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma","volume":"83","author":"Pelicci","year":"1986","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.yexmp.2018.11.008_bb0295","series-title":"Classification of Non-Hodgkin Lymphoma in Seven Geographic Regions around the World: Review of 4539 Cases from the International Non-Hodgkin Lymphoma Classification Project","author":"Perry","year":"2015"},{"key":"10.1016\/j.yexmp.2018.11.008_bb0300","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, revised 4th edn","first-page":"403","article-title":"Peripheral T cell lymphoma, NOS","author":"Pileri","year":"2017"},{"key":"10.1016\/j.yexmp.2018.11.008_bb6655","doi-asserted-by":"crossref","first-page":"435983","DOI":"10.1155\/2014\/435983","article-title":"Genetic abnormalities in chronic lymphocytic leukemia: where we are and where we go","volume":"2014","author":"Puiggros","year":"2014","journal-title":"Biomed Res Int."},{"key":"10.1016\/j.yexmp.2018.11.008_bb0305","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, revised 4th edn","first-page":"223","article-title":"Splenic marginal zone lymphoma","author":"Pyris","year":"2017"},{"issue":"3","key":"10.1016\/j.yexmp.2018.11.008_bb0310","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/ajh.24282","article-title":"Chronic lymphocytic leukemia (CLL)\u2014then and now","volume":"91","author":"Rai","year":"2016","journal-title":"Am. J. Hematol."},{"issue":"8","key":"10.1016\/j.yexmp.2018.11.008_bb0315","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1182\/blood-2012-09-458265","article-title":"Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia","volume":"121","author":"Rossi","year":"2013","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.yexmp.2018.11.008_bb8855","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1200\/JCO.1988.6.5.919","article-title":"Chromosome studies in the non-Hodgkin's lymphomas: the role of the 14; 18 translocation","volume":"6","author":"Rowley","year":"1988","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.yexmp.2018.11.008_bb0320","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a014282","article-title":"Oncogenic mechanisms in Burkitt lymphoma","volume":"4","author":"Schmitz","year":"2014","journal-title":"Cold Spring Harbor Perspect. Med."},{"issue":"15","key":"10.1016\/j.yexmp.2018.11.008_bb0325","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"5370","key":"10.1016\/j.yexmp.2018.11.008_bb0335","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1126\/science.280.5370.1750","article-title":"Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes","volume":"280","author":"Shen","year":"1998","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.yexmp.2018.11.008_bb0340","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/bjc.2015.94","article-title":"Lymphoma incidence, survival and prevalence 2004\u20132014: sub-type analyses from the UK's Haematological Malignancy Research Network","volume":"112","author":"Smith","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.yexmp.2018.11.008_bb0345","first-page":"90","article-title":"Diagnosis of \u2018double hit'diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC","volume":"2014","author":"Swerdlow","year":"2014","journal-title":"ASH Education Program Book"},{"key":"10.1016\/j.yexmp.2018.11.008_bb0350","first-page":"10","article-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008","journal-title":"Int. Agency Res. Cancer Lyon"},{"issue":"3","key":"10.1016\/j.yexmp.2018.11.008_bb0355","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00428-015-1858-9","article-title":"The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing","volume":"468","author":"Swerdlow","year":"2016","journal-title":"Virchows Arch."},{"issue":"20","key":"10.1016\/j.yexmp.2018.11.008_bb0360","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.yexmp.2018.11.008_bb0365","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, revised 4th edn","first-page":"232","article-title":"Lymphoplasmacytic lymphoma","author":"Swerdlow","year":"2017"},{"key":"10.1016\/j.yexmp.2018.11.008_bb0370","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, revised 4th edn","first-page":"285","article-title":"Mantle cell lymphoma","author":"Swerdlow","year":"2017"},{"issue":"24","key":"10.1016\/j.yexmp.2018.11.008_bb0375","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1014209","article-title":"BRAF mutations in hairy-cell leukemia","volume":"364","author":"Tiacci","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.yexmp.2018.11.008_bb0380","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1182\/blood.V84.4.1043.1043","article-title":"Prognostic value of chromosomal abnormalities in follicular lymphoma","volume":"84","author":"Tilly","year":"1994","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.yexmp.2018.11.008_bb0385","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3324\/haematol.2016.146571","article-title":"Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with the variant RNF213-, ATIC-and TPM3-ALK fusions is characterized by copy number gain of the rearranged ALK gene","volume":"102","author":"Van der Krogt","year":"2017","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.yexmp.2018.11.008_bb0390","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"Van Dongen","year":"2003","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.yexmp.2018.11.008_bb0395","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1182\/blood-2002-10-3306","article-title":"ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile","volume":"101","author":"Wiestner","year":"2003","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.yexmp.2018.11.008_bb0400","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/sj.leu.2403813","article-title":"FOXP1, a gene highly expressed in a subset of diffuse large B-cell lymphoma, is recurrently targeted by genomic aberrations","volume":"19","author":"Wlodarska","year":"2005","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.yexmp.2018.11.008_bb0405","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/10428194.2015.1064530","article-title":"Genetics of anaplastic large cell lymphoma","volume":"57","author":"Zeng","year":"2016","journal-title":"Leuk. Lymphoma"},{"issue":"17","key":"10.1016\/j.yexmp.2018.11.008_bb0410","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1182\/blood-2015-12-624304","article-title":"The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance","volume":"127","author":"Zucca","year":"2016","journal-title":"Blood"}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480018303265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480018303265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T02:49:33Z","timestamp":1757990973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480018303265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":87,"alternative-id":["S0014480018303265"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2018.11.008","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular and cellular genetics of non-Hodgkin lymphoma: Diagnostic and prognostic implications","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2018.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}